News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
346,520 Results
Type
Article (23307)
Company Profile (38)
Press Release (323175)
Multimedia
Podcasts (49)
Webinars (1)
Section
Business (100724)
Career Advice (460)
Deals (14963)
Drug Delivery (56)
Drug Development (44957)
Employer Resources (48)
FDA (10038)
Job Trends (7119)
News (169890)
Policy (14534)
Tag
Academia (1505)
Accelerated approval (2)
Adcomms (9)
Allergies (44)
Alliances (24372)
ALS (66)
Alzheimer's disease (995)
Antibody-drug conjugate (ADC) (45)
Approvals (10064)
Artificial intelligence (191)
Autoimmune disease (8)
Automation (9)
Bankruptcy (120)
Best Places to Work (6334)
BIOSECURE Act (6)
Biosimilars (40)
Biotechnology (27)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (214)
Cancer (1530)
Cardiovascular disease (143)
Career advice (407)
Career pathing (7)
CAR-T (48)
Cell therapy (154)
Cervical cancer (19)
Clinical research (38123)
Collaboration (429)
Compensation (89)
Complete response letters (9)
COVID-19 (1617)
CRISPR (14)
C-suite (84)
Cystic fibrosis (45)
Data (1553)
Decentralized trials (1)
Denatured (20)
Depression (16)
Diabetes (297)
Diagnostics (6492)
Digital health (11)
Diversity (3)
Diversity, equity & inclusion (15)
Drug discovery (73)
Drug pricing (53)
Drug shortages (26)
Duchenne muscular dystrophy (52)
Earnings (52950)
Editorial (21)
Employer branding (7)
Employer resources (42)
Events (44870)
Executive appointments (272)
FDA (10836)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (333)
Gene editing (30)
Generative AI (16)
Gene therapy (139)
GLP-1 (639)
Government (2275)
Grass and pollen (2)
Guidances (75)
Healthcare (9628)
Huntington's disease (12)
IgA nephropathy (19)
Immunology and inflammation (48)
Indications (17)
Infectious disease (1690)
Inflammatory bowel disease (83)
Inflation Reduction Act (3)
Influenza (30)
Intellectual property (33)
Interviews (69)
IPO (7307)
IRA (20)
Job creations (1096)
Job search strategy (354)
Kidney cancer (8)
Labor market (12)
Layoffs (162)
Leadership (3)
Legal (2087)
Liver cancer (52)
Lung cancer (249)
Lymphoma (99)
Machine learning (5)
Management (13)
Manufacturing (155)
MASH (56)
Medical device (7978)
Medtech (7981)
Mergers & acquisitions (7863)
Metabolic disorders (639)
Multiple sclerosis (54)
NASH (16)
Neurodegenerative disease (56)
Neuropsychiatric disorders (7)
Neuroscience (1314)
NextGen: Class of 2025 (2652)
Non-profit (2564)
Now hiring (6)
Obesity (317)
Opinion (93)
Ovarian cancer (47)
Pain (39)
Pancreatic cancer (60)
Parkinson's disease (81)
Partnered (10)
Patents (93)
Patient recruitment (64)
Peanut (26)
People (20784)
Pharmaceutical (8)
Pharmacy benefit managers (4)
Phase I (9295)
Phase II (16683)
Phase III (14947)
Pipeline (773)
Policy (50)
Postmarket research (1695)
Preclinical (3241)
Press Release (19)
Prostate cancer (84)
Psychedelics (8)
Radiopharmaceuticals (197)
Rare diseases (194)
Real estate (2017)
Recruiting (17)
Regulatory (11429)
Reports (23)
Research institute (1583)
Resumes & cover letters (59)
Rett syndrome (1)
RNA editing (2)
RSV (15)
Schizophrenia (41)
Series A (42)
Series B (30)
Service/supplier (2)
Sickle cell disease (25)
Special edition (11)
Spinal muscular atrophy (101)
Sponsored (17)
Startups (1384)
Stomach cancer (9)
Supply chain (33)
Tariffs (7)
The Weekly (28)
Vaccines (378)
Venture capitalists (13)
Weight loss (220)
Women's health (16)
Worklife (1)
Date
Today (171)
Last 7 days (468)
Last 30 days (1537)
Last 365 days (17455)
2025 (5963)
2024 (18680)
2023 (21257)
2022 (30948)
2021 (31943)
2020 (29491)
2019 (23177)
2018 (17636)
2017 (17375)
2016 (16315)
2015 (19201)
2014 (14357)
2013 (11828)
2012 (12831)
2011 (13192)
2010 (11809)
Location
Africa (329)
Alabama (16)
Alaska (2)
Arizona (112)
Arkansas (9)
Asia (18689)
Australia (3467)
California (3076)
Canada (1149)
China (241)
Colorado (154)
Connecticut (153)
Delaware (95)
Europe (47212)
Florida (444)
Georgia (130)
Idaho (17)
Illinois (308)
India (18)
Indiana (198)
Iowa (5)
Japan (92)
Kansas (75)
Kentucky (20)
Louisiana (2)
Maine (62)
Maryland (451)
Massachusetts (2091)
Michigan (131)
Minnesota (270)
Mississippi (2)
Missouri (49)
Montana (14)
Nebraska (13)
Nevada (27)
New Hampshire (49)
New Jersey (973)
New Mexico (20)
New York (986)
North Carolina (586)
North Dakota (6)
Northern California (1407)
Ohio (103)
Oklahoma (3)
Oregon (21)
Pennsylvania (558)
Puerto Rico (2)
Rhode Island (12)
South America (492)
South Carolina (12)
Southern California (1151)
Tennessee (56)
Texas (577)
United States (12123)
Utah (139)
Virginia (89)
Washington D.C. (30)
Washington State (265)
West Virginia (2)
Wisconsin (44)
346,520 Results for "dia imaging analysis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
BioSpace at #DIA2024: Convergence and Collaboration
BioSpace’s Lori Ellis and Chantal Dresner bring live updates from the first day of #DIA2024 in San Diego.
June 17, 2024
·
1 min read
Policy
Cautiously Stepping Into the Future of AI by Stepping Back Into the Past at DIA’s MASC
GenAI, the youngest of the AI family, is evolving quickly. The global life sciences industry is attempting to evolve with it. However, as a keynote session at DIA’s MASC suggests, taking a pause to understand AI risks and to prepare to comply with the EU AI Act is what is needed.
March 19, 2024
·
5 min read
·
Lori Ellis
BioSpace at #DIA2024: Workforce Trends, Trial Design, Peter Marks & Recap
BioSpace’s Lori Ellis and Chantal Dresner bring live updates from day three of #DIA2024 in San Diego.
June 20, 2024
·
1 min read
IN PARTNERSHIP WITH DIA
Beyond Neutrality: How Nonprofit Organizations Drive Healthcare Innovation and Collaboration
Health-focused nonprofits like the Drug Information Association (DIA) serve as crucial bridge-builders in the healthcare ecosystem during a time of uncertainty.
April 7, 2025
·
7 min read
·
BioSpace Insights
Drug Development
BioSpace x DIA: Navigating the Emergence of CGT Combination Products
BioSpace’s Lori Ellis discusses the risks and challenges of cell and gene therapy combination products with DIA speakers James Wabby, AbbVie and Rob Schulz, Suttons Creek, Inc.
May 22, 2024
·
1 min read
·
Lori Ellis
BioSpace x DIA: Advanced Therapy Product Regulatory Confusion
In this second episode of our collaboration with DIA, we discuss the challenging, collaborative process of regulating advanced therapy product development with guests James Wabby, AbbVie and Rob Schulz, Suttons Creek, Inc.
May 29, 2024
·
1 min read
Biotech Beach
Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, is embracing the theme of the 60th annual Drug Information Association (DIA) annual meeting today in San Diego – “Charting New Horizons.”
June 17, 2024
·
4 min read
BIOSECURE’s Surprise Absence, the $100+ Billion Future Weight-Loss Market, DIA and More
This week’s news ranged from BioSpace’s on-the-ground updates from DIA to safety concerns in clinical trials to BIOSECURE Act updates to new projections that the GLP-1 market could top $100 billion within 10 years.
June 18, 2024
·
2 min read
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH DIA
Breaking Down Barriers: The Nuanced Approach to Women’s Representation in Medical Research
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses the underrepresentation of women in clinical trials with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 10, 2025
·
1 min read
·
Lori Ellis
1 of 34,652
Next
